Ava L Liberman1, Gino Gialdini2,3, Ekaterina Bakradze4, Abhinaba Chatterjee2, Hooman Kamel2,3, Alexander E Merkler2,3. 1. From the Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (A.L.L., E.B.) avliberm@Montefiore.org. 2. Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (G.G., A.C., H.K., A.E.M.). 3. Department of Neurology, Weill Cornell Medicine, New York, NY (G.G., H.K., A.E.M.). 4. From the Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (A.L.L., E.B.).
Abstract
BACKGROUND AND PURPOSE: Rates of cerebral venous thrombosis (CVT) misdiagnosis in the emergency department and outcomes associated with misdiagnosis have been underexplored. METHODS: Using administrative data, we identified adults with CVT at New York, California, and Florida hospitals from 2005 to 2013. Our primary outcome was probable misdiagnosis of CVT, defined as a treat-and-release emergency department visit for headache or seizure within 14 days before CVT. In addition, logistic regression was used to compare rates of clinical outcomes in patients with and without probable CVT misdiagnosis. We performed a confirmatory study at 2 tertiary care centers. RESULTS: We identified 5966 patients with CVT in whom 216 (3.6%; 95% confidence interval [CI], 1.1%-4.1%) had a probable misdiagnosis of CVT. After adjusting for demographics, risk factors for CVT, and the Elixhauser comorbidity index, probable CVT misdiagnosis was not associated with in-hospital mortality (odds ratio, 0.14; 95% CI, 0.02-1.05), intracerebral hemorrhage (odds ratio, 0.97; 95% CI, 0.57-1.65), or unfavorable discharge disposition (odds ratio, 0.90; 95% CI, 0.61-1.32); a longer length of hospital stay was seen among misdiagnosed patients with CVT (odds ratio, 1.62; 95% CI, 1.04-2.50). In our confirmatory cohort, probable CVT misdiagnosis occurred in 8 of 134 patients with CVT (6.0%; 95% CI, 2.6%-11.4%). CONCLUSIONS: In a large, heterogeneous multistate cohort, probable misdiagnosis of CVT occurred in 1 of 30 patients but was not associated with the adverse clinical outcomes included in our study.
BACKGROUND AND PURPOSE: Rates of cerebral venous thrombosis (CVT) misdiagnosis in the emergency department and outcomes associated with misdiagnosis have been underexplored. METHODS: Using administrative data, we identified adults with CVT at New York, California, and Florida hospitals from 2005 to 2013. Our primary outcome was probable misdiagnosis of CVT, defined as a treat-and-release emergency department visit for headache or seizure within 14 days before CVT. In addition, logistic regression was used to compare rates of clinical outcomes in patients with and without probable CVT misdiagnosis. We performed a confirmatory study at 2 tertiary care centers. RESULTS: We identified 5966 patients with CVT in whom 216 (3.6%; 95% confidence interval [CI], 1.1%-4.1%) had a probable misdiagnosis of CVT. After adjusting for demographics, risk factors for CVT, and the Elixhauser comorbidity index, probable CVT misdiagnosis was not associated with in-hospital mortality (odds ratio, 0.14; 95% CI, 0.02-1.05), intracerebral hemorrhage (odds ratio, 0.97; 95% CI, 0.57-1.65), or unfavorable discharge disposition (odds ratio, 0.90; 95% CI, 0.61-1.32); a longer length of hospital stay was seen among misdiagnosed patients with CVT (odds ratio, 1.62; 95% CI, 1.04-2.50). In our confirmatory cohort, probable CVT misdiagnosis occurred in 8 of 134 patients with CVT (6.0%; 95% CI, 2.6%-11.4%). CONCLUSIONS: In a large, heterogeneous multistate cohort, probable misdiagnosis of CVT occurred in 1 of 30 patients but was not associated with the adverse clinical outcomes included in our study.
Authors: Joana Gameiro; José M Ferro; Patricia Canhão; Jan Stam; Fernando Barinagarrementeria; Arne Lindgren Journal: Cephalalgia Date: 2012-03-09 Impact factor: 6.292
Authors: Suzanne M Silvis; Saskia Middeldorp; Susanna M Zuurbier; Suzanne C Cannegieter; Jonathan M Coutinho Journal: Semin Thromb Hemost Date: 2016-06-06 Impact factor: 4.180
Authors: José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria; Ayrton Massaro; Xavier Ducrocq; Scott E Kasner Journal: Stroke Date: 2009-07-16 Impact factor: 7.914
Authors: José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria Journal: Stroke Date: 2004-02-19 Impact factor: 7.914
Authors: Julia Devianne; Nicolas Legris; Isabelle Crassard; Celine Bellesme; Yannick Bejot; Celine Guidoux; Fernando Pico; David Germanaud; Michael Obadia; Diana Rodriguez; Philippe Tuppin; Manoelle Kossorotoff; Christian Denier Journal: Neurology Date: 2021-09-20 Impact factor: 9.910
Authors: Ava L Liberman; Babak B Navi; Charles C Esenwa; Cenai Zhang; Justin Song; Natalie T Cheng; Daniel L Labovitz; Hooman Kamel; Alexander E Merkler Journal: Stroke Date: 2020-04-16 Impact factor: 7.914
Authors: Zohair Al Aseri; Mohamed Al Aqeel; Badr Aldawood; Fahad Albadr; Rawan Ghandour; Abdulaziz Al Mulaik; Mohammed A Malabarey; Anas Khan Journal: Comput Intell Neurosci Date: 2022-09-26